New Air-Jet Dry Powder Insufflator for High-Efficiency Aerosol Delivery to Rats-Reference-Cited by-同舟云学术

New Air-Jet Dry Powder Insufflator for High-Efficiency Aerosol Delivery to Rats

Published:2023-03-20 Issue:4 Volume:20 Page:2207-2216
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Pangeni Rudra¹^ORCID,Hassan Amr Ali Mohamed¹^ORCID,Farkas Dale²^ORCID,Sudarjat Hadi¹^ORCID,Longest Worth¹²,Hindle Michael¹^ORCID,Xu Qingguo¹³^ORCID

Affiliation:

1. Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia 23298, United States

2. Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, Virginia 23284, United States

3. Department of Ophthalmology, Massey Cancer Center, Center for Pharmaceutical Engineering, and Institute for Structural Biology, Drug Discovery & Development (ISB3D), Virginia Commonwealth University, Richmond, Virginia 23284, United States

Funder

George and Lavinia Blick Research Fund

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00007

Reference30 articles.

1. Pulmonary delivery of Nanocomposite Microparticles (NCMPs) incorporating miR-146a for treatment of COPD

2. Fumaryl diketopiperazine based effervescent microparticles to escape macrophage phagocytosis for enhanced treatment of pneumonia via pulmonary delivery

3. Drug delivery to the lungs: challenges and opportunities

4. Nanoporous CD-MOF particles with uniform and inhalable size for pulmonary delivery of budesonide

5. Inhalable nanoparticulate powders for respiratory delivery

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhalable tobramycin EEG powder formulation for treating Pseudomonas aeruginosa-induced lung infection;International Journal of Pharmaceutics;2024-09

2. Nasal delivery of encapsulated recombinant ACE2 as a prophylactic drug for SARS-CoV-2;International Journal of Pharmaceutics;2024-04

3. Designing inhaled small molecule drugs for severe respiratory diseases: an overview of the challenges and opportunities;Expert Opinion on Drug Discovery;2024-02-26

4. Lipid-Based Nanocarriers in the Management of Pulmonary Complications in Cystic Fibrosis;Current Respiratory Medicine Reviews;2023-11-03

5. Effects of different mesh nebulizer sources on the dispersion of powder formulations produced with a new small-particle spray dryer;International Journal of Pharmaceutics;2023-07